{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:05:29Z","timestamp":1785539129504,"version":"3.56.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"vor","delay-in-days":81,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.curtheres.2022.100668","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T01:47:27Z","timestamp":1648518447000},"page":"100668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Dasiglucagon Effects on QTc in Healthy Volunteers: A Randomized, Placebo-Controlled, Dose-Escalation, Double-Blind Study"],"prefix":"10.1016","volume":"96","author":[{"given":"Ramin","family":"Tehranchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Pettersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita E.","family":"Melgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedeborg","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Valeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stine Just","family":"Maarbjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.curtheres.2022.100668_bib0001","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1021\/acs.jmedchem.9b01493","article-title":"Structural Refinement of Glucagon for Therapeutic Use","volume":"63","author":"Chabenne","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.curtheres.2022.100668_bib0002","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1210\/er.2016-1078","article-title":"Vascular Biology of Glucagon Receptor Superfamily Peptides: Mechanistic and Clinical Relevance","volume":"37","author":"Pujadas","year":"2016","journal-title":"Endocr Rev"},{"key":"10.1016\/j.curtheres.2022.100668_bib0003","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1210\/jc.2018-00050","article-title":"Hemodynamic Effects of Glucagon: A Literature Review","volume":"103","author":"Petersen","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.curtheres.2022.100668_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016828","article-title":"High-Dose Glucagon Has Hemodynamic Effects Regardless of Cardiac Beta-Adrenoceptor Blockade: A Randomized Clinical Trial","volume":"9","author":"Petersen","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.curtheres.2022.100668_bib0005","article-title":"Glucagonoma-induced acute heart failure","volume":"2014","author":"Zhang","year":"2014","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.curtheres.2022.100668_bib0006","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1136\/hrt.2004.036905","article-title":"Reversible dilated cardiomyopathy associated with glucagonoma","volume":"90","author":"Chang-Chretien","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.curtheres.2022.100668_bib0007","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1161\/01.HYP.30.5.1267","article-title":"Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations","volume":"30","author":"Palatini","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.curtheres.2022.100668_bib0008","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2337\/dc17-1402","article-title":"Pharmacokinetic and Pharmacodynamic Characteristics of Dasiglucagon, a Novel Soluble and Stable Glucagon Analog","volume":"41","author":"Hovelmann","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.curtheres.2022.100668_bib0009","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2337\/dc20-2995","article-title":"Dasiglucagon: A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia Results of Phase 3 Randomized Double-Blind Clinical Trial","volume":"44","author":"Pieber","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.curtheres.2022.100668_bib0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10928-017-9558-5","article-title":"Scientific white paper on concentration-QTc modeling","volume":"45","author":"Garnett","year":"2018","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.curtheres.2022.100668_bib0011","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1365-2125.2012.04376.x","article-title":"Insulin at normal physiological levels does not prolong QT(c) interval in thorough QT studies performed in healthy volunteers","volume":"75","author":"Taubel","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.curtheres.2022.100668_bib0012","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/jcph.1374","article-title":"The Cardiovascular Effects of a Meal: J-Tpeak and Tpeak-Tend Assessment and Further Insights Into the Physiological Effects","volume":"59","author":"Taubel","year":"2019","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.curtheres.2022.100668_bib0013","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s001250051345","article-title":"The effect of acute hyperglycaemia on QTc duration in healthy man","volume":"43","author":"Marfella","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.curtheres.2022.100668_bib0014","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/jcph.933","article-title":"Influence of Meals and Glycemic Changes on QT Interval Dynamics","volume":"57","author":"Cirincione","year":"2017","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.curtheres.2022.100668_bib0015","doi-asserted-by":"crossref","first-page":"R2022","DOI":"10.1152\/ajpregu.2000.279.6.R2022","article-title":"Insulin prolongs the QTc interval in humans","volume":"279","author":"Gastaldelli","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.curtheres.2022.100668_bib0016","unstructured":"Global Instrumentations. M12 Holter & ECG recorder. 2021. Accessed August 16, 2021. https:\/\/www.globalinstrumentation.com\/gimedical\/Products\/Clinical-Research-Cardiac-Safety\/M12R-Holter-ECG-Recorder."},{"key":"10.1016\/j.curtheres.2022.100668_bib0017","first-page":"401","article-title":"Improving the precision of QT measurements","volume":"18","author":"Darpo","year":"2011","journal-title":"Cardiol J"},{"key":"10.1016\/j.curtheres.2022.100668_bib0018","first-page":"773","article-title":"Immunogenicity of the Novel Glucagon Analogue Dasiglucagon: Results of a Dedicated Immunogenicity Trial in Type 1 Diabetes","volume":"23","author":"Pieber","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.curtheres.2022.100668_bib0019","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1542-474X.2003.08413.x","article-title":"The duration of systole in an electrocardiogram in normal humans and in patients with heart disease. 1920","volume":"8","author":"Fridericia","year":"2003","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.curtheres.2022.100668_bib0020","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1161\/01.CIR.60.6.1401","article-title":"Sudden, unexpected death in avid dieters using the liquid-protein-modified-fast diet. Observations in 17 patients and the role of the prolonged QT interval","volume":"60","author":"Isner","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.curtheres.2022.100668_bib0021","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/j.1550-8528.1997.tb00573.x","article-title":"QTc interval (cardiac repolarization): lengthening after meals","volume":"5","author":"Nagy","year":"1997","journal-title":"Obes Res"},{"key":"10.1016\/j.curtheres.2022.100668_bib0022","unstructured":"Zealand Pharma A\/S. Zegalogue (dasiglucagon) for injection. 2021. Accessed March 29, 2021. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/214231s000lbl.pdf."}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X22000078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X22000078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:58:46Z","timestamp":1757897926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X22000078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":22,"alternative-id":["S0011393X22000078"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2022.100668","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dasiglucagon Effects on QTc in Healthy Volunteers: A Randomized, Placebo-Controlled, Dose-Escalation, Double-Blind Study","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2022.100668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100668"}}